Literature DB >> 11867197

Inhibition of conjugated fatty acids derived from safflower or perilla oil of induction and development of mammary tumors in rats induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Mitsuru Futakuchi1, Jing Lei Cheng, Masao Hirose, Naoya Kimoto, Young Man Cho, Toshio Iwata, Masaaki Kasai, Shinkan Tokudome, Tomoyuki Shirai.   

Abstract

Chemopreventive effects of conjugated fatty acids derived from safflower oil (CFA-S), which contains large amounts of conjugated linoleic acid, and from perilla oil (CFA-P) with abundant conjugated alpha-linolenic acid were examined in a 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary carcinogenesis model. Groups of 20-22 6-week-old female Sprague-Dawley (SD) rats were given eight intragastric injections of PhIP at a dose of 100 mg/kg b.w. during the initial 8 week period. Powdered basal diets containing 0.1% CFA-S or CFA-P were applied during or after PhIP treatment until week 40. In the rats receiving CFA-S or CFA-P together with PhIP treatment, retardation of mammary tumor emergence was observed until week 27. The groups given CFA-S or CFA-P after PhIP treatment, in contrast, demonstrated significant decrease in the final incidences of mammary adenocarcinomas. The indices of proliferating cell nuclear antigen positive cells in mammary adenocarcinomas were significantly reduced with both CFA-S and CFA-P in the post-initiation phase. Formation of aberrant crypt foci in the colon and basophilic foci of the pancreas due to the PhIP treatment group were not affected by CFA-S or CFA-P. In a second short-term experiment, female SD rats were maintained on powdered basal diet containing 0.03% PhIP alone or together with 0.1% CFA-S or CFA-P for 4 weeks. Immunohistochemically, CFA-S and CFA-P were revealed to suppress PhIP-DNA adduct formation in the epithelial cells of mammary gland (duct and alveolar cells), colon and pancreas. These results indicated that CFA-P and CFA-S may retard development of PhIP-induced mammary tumors with inhibition of PhIP-DNA adduct formation, and decreased mammary carcinogenesis in the post-initiation period with inhibition of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867197     DOI: 10.1016/s0304-3835(01)00860-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Inhibitory effect of conjugated alpha-linolenic acid from bifidobacteria of intestinal origin on SW480 cancer cells.

Authors:  Mairéad Coakley; Sebastiano Banni; Mark C Johnson; Susan Mills; Rosaleen Devery; Gerald Fitzgerald; R Paul Ross; Catherine Stanton
Journal:  Lipids       Date:  2008-12-02       Impact factor: 1.880

Review 2.  Dietary factors modifying breast cancer risk and relation to time of intake.

Authors:  Airo Tsubura; Norihisa Uehara; Yasuhiko Kiyozuka; Nobuaki Shikata
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-01       Impact factor: 2.673

3.  Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid.

Authors:  Jia-Ren Liu; Bing-Qing Chen; Yan-Mei Yang; Xuan-Ling Wang; Ying-Ben Xue; Yu-Mei Zheng; Rui-Hai Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

4.  Dietary perilla oil inhibits proinflammatory cytokine production in the bronchoalveolar lavage fluid of ovalbumin-challenged mice.

Authors:  Hui-Hsiang Chang; Chin-Shun Chen; Jin-Yuarn Lin
Journal:  Lipids       Date:  2008-04-02       Impact factor: 1.880

5.  Apiaceous Vegetables and Cruciferous Phytochemicals Reduced PhIP-DNA Adducts in Prostate but Not in Pancreas of Wistar Rats.

Authors:  Jae Kyeom Kim; Marissa A McCormick; Cynthia M Gallaher; Daniel D Gallaher; Sabrina P Trudo
Journal:  J Med Food       Date:  2018-02       Impact factor: 2.786

6.  Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action.

Authors:  Miki Tsujita-Kyutoku; Takashi Yuri; Naoyuki Danbara; Hideto Senzaki; Yasuhiko Kiyozuka; Norihisa Uehara; Hideho Takada; Takahiko Hada; Teruo Miyazawa; Yutaka Ogawa; Airo Tsubura
Journal:  Breast Cancer Res       Date:  2004-04-26       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.